HowShorted

How shorted is INmune Bio Inc.?

More shorted than 73% of the 2,877 ranked US companies

8.29%
of shares outstanding reported short · settlement date 31 Jul 2026
vs previous report
−0.68
5 reports (~10 weeks)
−5.41
Aggregate net short position time series for INmune Bio Inc.
Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Cite this page

History

Settlement dateShort %Change
31 Jul 20268.29%−0.68
15 Jul 20268.97%−2.57
30 Jun 202611.54%−2.26
15 Jun 202613.80%−0.08
29 May 202613.88%+0.18
15 May 202613.70%+0.38
30 Apr 202613.32%+0.65
15 Apr 202612.67%−0.22
31 Mar 202612.89%+0.64
13 Mar 202612.25%−2.07
27 Feb 202614.32%−0.59
13 Feb 202614.91%−0.31
30 Jan 202615.22%+0.56
15 Jan 202614.66%+2.47
31 Dec 202512.19%−0.67
15 Dec 202512.86%+1.10
28 Nov 202511.76%−1.22
14 Nov 202512.98%+0.97
31 Oct 202512.01%−1.07
15 Oct 202513.08%+0.74
30 Sep 202512.34%−0.17
15 Sep 202512.51%−1.55
29 Aug 202514.06%−5.99
15 Aug 202520.05%−6.04
31 Jul 202526.09%–

Frequently asked questions

How shorted is INmune Bio Inc. right now?
8.29% of INmune Bio Inc.'s (INMB) shares outstanding were reported short for settlement date 31 Jul 2026, per FINRA's consolidated short interest report.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.